Wang WY, Liu N, Qi XX, Han B, Sun JN, Chen ZL, Wang MW, Wang YY. Predictive effect of lipopolysaccharide-stimulated inflammatory cytokines on symptoms of generalized anxiety disorder. World J Psychiatry 2024; 14(9): 1308-1318 [PMID: 39319223 DOI: 10.5498/wjp.v14.i9.1308]
Corresponding Author of This Article
Yan-Yong Wang, MD, Chief Doctor, Department of Neurology, The First Hospital of Hebei Medical University, No. 89 Donggang Road, Shijiazhuang 050000, Hebei Province, China. 57600267@hebmu.edu.cn
Research Domain of This Article
Neurosciences
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatry. Sep 19, 2024; 14(9): 1308-1318 Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1308
Table 1 Demographic and clinical characteristics, n (%)
Index
Control group
Generalized anxiety disorder group
t/χ2
P value
Age (yr)
53.79 ± 16.23
58.30 ± 13.70
1.863
0.065
Sex (male/female)
25/45
39/50
1.812
0.178
Body mass index (kg/m2)
24.55 ± 2.06
24.46 ± 3.24
0.291
0.760
Smoking history
19 (27.14)
18 (20.22)
1.050
0.305
Drinking history
9 (12.85)
8 (8.99)
0.001
0.529
Diabetes
10 (14.29)
13 (14.60)
0.030
0.954
Hypertension
33 (47.14)
46 (51.69)
0.323
0.570
Coronary heart disease
8 (11.42)
18 (20.22)
2.216
0.137
Hyperlipidemia
7 (10.00)
10 (11.23)
0.063
0.802
Cerebral infarction
10 (14.28)
15 (16.85)
0.195
0.659
Table 2 Comparison of levels of inflammation-related cytokines between the two groups
Inflammatory factor (normal range)
Control group (mean ± SD)
Generalized anxiety disorder group (mean ± SD)
t value
P value
IL-1β (0-12.4 pg/mL)
1.69 ± 1.04
1.96 ± 2.21
1.024
0.308
IL-2 (0-5.71 pg/mL)
1.45 ± 0.98
1.78 ± 1.40
1.684
0.094
IL-4 (0-3 pg/mL)
1.68 ± 1.14
2.19 ± 1.82
2.040
0.043
IL-5 (0-3.10 pg/mL)
1.27 ± 0.58
2.18 ± 1.80
4.044
0.001
IL-6 (0-7 pg/mL)
5.03 ± 3.11
5.06 ± 3.98
-0.40
0.968
IL-8 (0-20.60 pg/mL)
30.59 ± 41.33
57.53 ± 230.29
1.081
0.336
IL-10 (0-4.91 pg/mL)
2.30 ± 0.82
3.66 ± 5.86
2.163
0.056
TNF-α (0-4.60 pg/mL)
2.05 ± 1.25
2.42 ± 2.67
1.069
0.287
IFN-γ (0-7.42 pg/mL)
1.77 ± 1.29
2.02 ± 1.59
1.056
0.292
IL-17A (0-20.6 pg/mL)
7.23 ± 4.84
4.27 ± 4.42
-3.749
0.001
IL-12p70 (0-3.4 pg/mL)
2.07 ± 1.40
2.55 ± 2.54
1.443
0.151
IFN-α (0-8.5 pg/mL)
1.80 ± 1.20
3.42 ± 10.42
1.460
0.148
Table 3 Inflammation-related cytokine levels after lipopolysaccharide stimulation
Inflammatory factor (normal range)
Control group (mean ± SD)
Generalized anxiety disorder group (mean ± SD)
t value
P value
IL-1β (0-12.4 pg/mL)
1592.06 ± 622.43
1538.99 ± 844.21
-0.440
0.660
IL-2 (0-5.71 pg/mL)
1.12 ± 0.67
1.13 ± 0.85
0.082
0.935
IL-4 (0-3 pg/mL)
1.44 ± 0.75
1.25 ± 0.77
-1.568
0.119
IL-5 (0-3.10 pg/mL)
1.09 ± 0.68
1.04 ± 0.39
-0.625
0.534
IL-6 (0-7 pg/mL)
14354.85 ± 1420.62
14657.66 ± 3347.42
0.173
0.443
IL-8 (0-20.60 pg/mL)
9515.79 ± 3803.61
11351.12 ± 6349.79
2.306
0.025
IL-10 (0-4.91 pg/mL)
1244.80 ± 2727.53
1049.45 ± 2877.97
-0.433
0.665
TNF-α (0-4.60 pg/mL)
2666.29 ± 1272.87
3197.81 ± 1887.78
1.676
0.045
IFN-γ (0-7.42 pg/mL)
34.72 ± 166.81
23.77 ± 74.81
-0.553
0.581
IL-17 (0-20.6 pg/mL)
26.91 ± 22.767
28.78 ± 30.53
0.426
0.671
IL-12p70 (0-3.4 pg/mL)
2.50 ± 2.84
1.94 ± 1.44
-1.633
0.104
IFN-α (0-8.5 pg/mL)
2.42 ± 2.24
2.01 ± 2.21
-1.181
0.240
Table 4 Correlation between inflammatory factors and Hamilton Anxiety Rating Scale scores
Inflammatory factor
Correlation with HAMA scores before LPS stimulation
Correlation with HAMA scores after LPS- stimulation
r value
P value
r value
P value
IL-1β
0.118
0.271
0.219
0.039
IL-2
0.131
0.220
-0.20
0.852
IL-4
0.106
0.322
0.663
0.558
IL-5
-0.087
0.420
-0.042
0.698
IL-6
0.058
0.590
0.379
< 0.001
IL-8
0.149
0.164
0.640
< 0.001
IL-10
0.050
0.640
-2.92
0.005
TNF-α
0.108
0.313
0.621
< 0.001
IFN-γ
0.049
0.647
0.153
0.151
IL-17A
0.245
0.021
0.138
0.197
IL-12p70
0.118
0.270
0.091
0.399
IFN-α
0.036
0.737
0.144
0.178
Table 5 Correlation between inflammatory factors and mental anxiety and somatic anxiety
Inflammatory factor
Correlation with mental anxiety
Correlation with somatic anxiety
r value
P value
r value
P value
IL-1β
0.148
0.166
0.236
0.026
IL-6
0.374
< 0.0001
0.304
0.004
IL-8
0.495
< 0.0001
0.587
< 0.0001
IL-10
-0.224
< 0.035
-0.307
0.003
TNF-α
0.644
< 0.0001
0.503
< 0.0001
Table 6 Correlation between inflammatory factors and factors of somatic anxiety
Somatic anxiety factor (symptoms)
Correlation with inflammatory factors
IL-1β
IL-8
IL- 10
r value
P value
r value
P value
r value
P value
Muscular system
0.26
0.808
0.175
0.101
-0.20
0.853
Sensory system
0.143
0.182
0.114
0.288
-1.69
0.114
Cardiovascular system
0.30
0.004
0.119
0.265
0.029
0.788
Respiratory system
0.012
0.908
0.118
0.273
-0.092
0.392
Gastrointestinal system
-0.052
0.630
0.027
0.801
-0.503
< 0.0001
Genitourinary system
0.102
0.341
0.322
0.002
-0.124
0.245
Autonomic nervous system
0.077
0.471
0.517
< 0.0001
-0.040
0.707
Citation: Wang WY, Liu N, Qi XX, Han B, Sun JN, Chen ZL, Wang MW, Wang YY. Predictive effect of lipopolysaccharide-stimulated inflammatory cytokines on symptoms of generalized anxiety disorder. World J Psychiatry 2024; 14(9): 1308-1318